articleThe LancetNov 1, 2004Closed access

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

Dartmouth College · McGill University · +12 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,643
total citations
FWCI
109.17
Percentile
100%
References
43
Citations per year

Authors

16

Topics & keywords

Keywords
  • Medicine
  • Vaccine efficacy
  • Vaccination
  • Immunogenicity
  • HPV infection
  • Adjuvant
  • HPV vaccines
  • Cervical cancer
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding